Ivermectin in Cancer: Mechanisms and Trials

n this video, Dr. Kulmeet Kundlas discusses a recent study supported by Governor Ron DeSantis and the Florida Innovation Cancer Fund exploring Ivermectin’s potential role in cancer treatment. Dr. Kundlas provides a deep dive into the proposed mechanisms through which Ivermectin may inhibit tumor proliferation, disrupt cancer cell signaling pathways, enhance apoptotic processes, and expose cancer cells to immunotherapy and chemotherapy. While emphasizing that Ivermectin is not currently FDA-approved for cancer treatment, he highlights its promise as a cost-effective, orally administered drug with potential applications in lower-resource settings. Current research topics like breast cancer, prostate cancer, glioblastoma, ovarian cancer, and leukemia are also covered. Additionally, Dr. Kundlas notes ongoing studies on Ivermectin in epilepsy, neuroinflammation, and depression, suggesting future videos for further discussion. Subscribe to stay updated!